420 with CNW – 4 Tips for Choosing the Best Marijuana Genetics

No one can blame you for wanting to jump right into the cannabis industry. Still pretty young, the industry is projected to be worth $73 billion by 2027, and hundreds of businesses want a piece of the cake. If you’re a complete beginner looking to make a name for yourself as a grower, your first priority is to find the best marijuana genetics. However, that’s no easy task, especially in an industry that’s only a few years old and barely has any standardized regulations.

For starters, make sure you do plenty of research. Marijuana is probably one of the most genetically diverse plants out there. It took award-winning cannabis breeder Mean Gene years to know “what is what” when it comes to cannabis genetics, and his advice to beginners is to seek advice from someone who’s had experience growing marijuana. There’s no standard manual for how to cater to different genetics, so it pays to get insight from someone who has had the first-hand experience. At massive seed purchasing events like the Emerald Cup, Gene recommends standing in line and getting other people’s feedback.

Pay heed to the generation of the seeds. Usually, breeders work to find the optimal version of a strain they’ve created by stabilizing the genetics through the subsequent generations. If you’re looking for a strain with a history of consistent results, look for later generations, rather than 1st generation genetics, such as Mean Gene’s Pop Kush F3.

Grow seeds most suitable for your area. Despite its rather quick growing time, farming cannabis can be quite troublesome. The best way to ensure the plants grow healthy is to find genetics that have been bred for the area you will farm in. The genetics will be best adapted to environmental factors like climate and soil. As Nikki Lastreto, one of the brains behind Swami Select says, choosing genetics means finding the seeds bred in your area.

Accept the results. At the end of the day, those seeds are in the ground and once they do, you lose any control you had. While you can ensure the plant is adequately nourished and protected as it grows, how it turns out will largely depend on the genetics you chose. Cannabis is especially tricky as a single plant has both male and female genders, so their final genders will be a surprise to you. Although some companies sell feminized seeds that produce pollen sacks instead of flowers and then pollinate the female plant with the female pollen, Lastreto says she prefers being surprised by unfeminized seeds.

“You have to accept that when you’re growing from seed, you don’t know what you’re going to get.” That thrill of the journey is probably what enticed companies like VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) into the sector, plus the desire to use this plant to make a contribution to people’s lives.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Why Verified Product Reviews Are Crucial for the Cannabis Industry

The cannabis industry is one of the fastest-growing industries in the country, with as many as 243,700 Americans employed in the legal cannabis industry as of early 2020. It’s a relatively young industry with a large amount of sellers and the number is sure to increase as more states legalize cannabis. However, that’s not the only way the legal cannabis industry differs from most ‘traditional’ industries. Cannabis holds the distinction of one of the few products on state shelves that is federally prohibited.

Still, medical cannabis has plenty of health benefits, ranging from relieving chronic pain and regulating and preventing diabetes to regulating seizures and alleviating anxiety. But how do you choose a high quality, effective product in an unevenly regulated market filled with thousands upon thousands of products? Marketplaces like Amazon found out the answer long ago: verified product reviews.

For novices buying legal cannabis, the best you can do is listen to your local budtender and through trial and error, find what works best for you. But not everyone has or wants to spend time having informed discussions with a budtender, especially as more and more dispensaries take their sales online. What consumers want and need is a failsafe way to ensure the products they intend to buy actually work, and Amazon provided that.

The e-commerce giant has long integrated customer reviews into its sales process, with customers being encouraged to review the products they purchase. This allows new customers to get a truthful, unbiased look at someone else’s experience with the product. Social proof, our tendency to reflect on the actions of others before we make a similar choice, is crucial to the shopping experience. The catch is that you can’t have big brands or ads endorsing your product, it has to be the people.

Integrating verified product reviews into online cannabis markets is one of the best ways to build consumer trust. Although some legacy platforms have product reviews, the fact that they aren’t verified makes them virtually worthless. Anyone can write such a review, from the seller themselves to competition who aren’t afraid to play dirty. When there are barely any established brands to trust and loads of sellers are pushing their products, people will believe word of mouth best. Verified product reviews from customers who have already purchased and used the product in question are the social proof both consumers and sellers of cannabis products need.

It would be interesting to learn how established companies like VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) have handled this issue to giving customers access to authentic feedback from previous product buyers.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – White House Official Admits Fewer Teens Are Using Marijuana Since Legalization

The road to cannabis legalization has been long and full of obstacles. While drug reform activists have preached the social and economic benefits of legalizing cannabis, proponents against legalization have argued that making cannabis legal and accessible to the public will lead to teens abusing the drug. However, according to an official from the White House’s anti-drug office, the consumption of cannabis by teens has fallen in Colorado and other states that have legalized marijuana for adult consumption.

Speaking to a committee of North Dakota lawmakers on Wednesday, Dale Quigley stated that “for some reason, the use rate among this age bracket is going down.” He is the deputy coordinator for the National Marijuana Initiative, a project of the High-Intensity Drug Trafficking Area (“HIDTA”) program. Although he can’t pin down why use rates among teens has been reducing in the state, the trend has been seen nationally.

“In looking at the state of Colorado for 12 to 17-year-old current use, we had a spike in ’14 but overall the use rates in Colorado have been declining, and that matches what we’re seeing in other states and also the trend we’re seeing nationally,” says Quigley, currently a resident of Colorado and a law enforcement officer since 1979. His comments were made during a wide-ranging presentation on the impacts of cannabis legalization to the North Dakota lawmakers. He used data from the U.S. Substance Abuse and Mental Health Services Organization (“SAMHSA”), which defines ‘current use’ as cannabis use within the past thirty days.

The HDTA program, which funds the National Marijuana Initiative, was established under the White House Office of National Drug Control Policy after Congress passed the Anti-Drug Abuse Act of 1988. According to the Marijuana Initiative’s website, it “strives to dispel misconceptions about marijuana and raise awareness of issues surrounding the drug.” It provides policymakers with speakers on cannabis issues, with presentations ranging from 60 minutes to 8 hours.

Quigley posits that youth may be scared of potent products and vaping. “We’re hearing anecdotal stories about kids that are afraid of the potency levels, you know, teens that have had adverse reactions to vaping and concentrates,” he says. Meanwhile, the committee of North Dakota lawmakers is expected to issue a report on marijuana legalization sometime this fall, most likely in November.

Experts say that when anti-marijuana officials like Quigley begin admitting that benefits are accruing from legalization at state level, companies like VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) get renewed hope that a change of policy at the federal level isn’t far off.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) Announces Scheduled Release of Q2 2020 Results, Conference Call

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) on Monday announced that it will release its second quarter 2020 results after the close of markets on Friday, August 14, 2020. According to the update, senior management will host a conference call to discuss the results at 11 a.m. ET on Monday, August 17, 2020. Interested parties may join the call by dialing 647-427-7450 or 1-888-231-8191 and entering conference ID: 8762205. Participants may register for and log into the live webcast at http://cnw.fm/JH267. The webcast will be archived for 90 days.

To view the full press release, visit http://cnw.fm/NJvdA

About VIVO Cannabis(TM)

VIVO Cannabis(TM) is recognized for trusted, premium cannabis products and services. It holds production and sales licenses from Health Canada and operates world-class indoor and seasonal airhouse cultivation facilities with proprietary plant-growing technology in Hope, British Columbia and Napanee, Ontario. VIVO has a collection of premium brands, each targeting different customer segments, including Canna Farms(TM), Beacon Medical(TM), Fireside(TM), Fireside X(TM), Lumina(TM) and Canadian Bud Collection(TM). The Company is expanding its production capabilities and distribution network. Harvest Medicine, VIVO’s patient-centric, scalable network of medical cannabis clinics, has serviced over 100,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia. The Company has a healthy balance sheet and is well-positioned to accelerate its path to profitability. For more information visit www.VIVOCannabis.com.

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://cnw.fm/VIVO

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Opponents File Lawsuit against Arizona Marijuana Ballot Measure

At the start of the year, at least 10 states had plans to legalize either medical or recreational cannabis. But as the coronavirus took hold, lawmakers didn’t have enough time to discuss comprehensive marijuana reforms. This, coupled with the shutdown and social distancing measures, meant states like New York and Ohio had to postpone their legalization plans. In Arizona, however, activists were able to collect enough signatures to get marijuana legalization on the November ballot, but they are now facing another potential hurdle.

A group opposed to legal cannabis has filed a lawsuit arguing that the initiative used deceptive language when collecting signatures and is asking a Maricopa County Superior Court judge to declare the initiative invalid. The lawsuit was filed by Arizonians for Health and Public Safety. It claims that the sponsors of the initiative did not adequately describe the measure in a 100-word summary that was included in the petition that voters signed. The group argues that the summary should have included or at least expanded on a number of the details contained in the 16-page initiative.

The lawsuit argues that the summary should have made it clear to voters that legalizing marijuana under the proposed initiative would also legalize marijuana concentrate. “The proponent’s summary of the initiative is confusing and deceptive in numerous ways, beginning with the very definition of marijuana,” says former Congressman John Shadegg, one of the attorneys who filed the lawsuit.

Additionally, the lawsuit states that the summary’s claim that the initiative would “protect employer and property owner rights” is misleading as well. The group also argues that the summary should have explained how governments could not tax marijuana on top of the proposed 16% rate. The lawsuit also states that the 100-word summary should have better explained how Arizonians under the age of 21 caught in possession of marijuana won’t receive felony charges. The initiative would set the legal age for possession at 21 and make underage marijuana possession a civil penalty.

According to Lisa James, Chairwoman of political action committee Arizonians for Health and Public Safety, “these omissions and statements misled voters who signed the petition about what the initiative would do.” However, Stacy Pearson, spokeswoman for the initiative campaign Smart and Safe Arizona, states that the lawsuit is without merit and only underscores what opponents would have wanted the 100-word summary to say, not what it was required to say. In 2018, the state Supreme Court ruled that although the 100-word summary of an initiative must state the initiatives ‘primary provisions’, it does not need to be impartial and does not need to detail every provision of a ballot measure.

Additionally, “there’s no way to incorporate a 15-page document or a 12-page document into a 100-word summary,” says Pearson. “We’re not particularly concerned and certainly the court has, over the years, favored direct democracy.”

Analysts say cannabis industry players like VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) will be interested in seeing how this legal battle pans out, as the outcome could reshape how ballot measures are drafted in future.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – FDA Finally Releases Cannabis Research Guidelines

In December 2018, Congress passed the 2018 Farm Bill, a landmark legislation that legalized the cultivation and sale of industrial hemp and it’s derivatives after decades of prohibition. Cannabidiol, a hemp extract with medical capabilities, quickly grew in popularity, resulting in an unregulated market worth millions of dollars in sales. For months, advocates, stakeholders, and some lawmakers have urged the U.S. Food and Drug Administration (“FDA”) to create a comprehensive regulatory structure for the industry.

On Tuesday, the agency finally released draft guidance on developing cannabis-based drugs, weeks after the White House announced that it had finished reviewing the draft guidance. The published document states that the guidance is “limited to the development of human drugs and does not cover other FDA regulated products.” As the FDA is still developing guidelines that would allow CBD to be marketed and sold as a food item or supplement, the draft document is meant to provide guidance for drug manufacturing.

“A range of stakeholders have expressed interest in the development of drugs that contain cannabis and other compounds found in cannabis. Recent legislative changes have also opened new opportunities for cannabis clinical research. As that body of research progresses and grows, the FDA is working to support drug development in this area,” says FDA Principal Deputy Commissioner Amy Abernethy. The legislative change she refers to is the 2018 Farm Bill which legalized industrial hemp with less than 0.3% THC. Thus, researchers can use industrial hemp from any source as long as it doesn’t have excess THC, not just from the University of Mississippi, the country’s only federally authorized marijuana manufacturer.

The new document stresses on THC testing, stating that sponsors and investigators may find it useful to calculate the level of delta-9 THC in their proposed investigational drug product early in the development process to gain insight into the potential control status of their product. “Regardless of whether cannabis or a cannabis-derived compound meets the definition of hemp, sponsors and applicants should work with reliable laboratories for analytical testing.”

It also gives step by step guidance on how to test for THC on a dry weight basis according to the FDA’s standards. In a Federal Register notice accompanying the new draft guidance, the agency asked for comments from the public on their recommended approach to testing for THC. The FDA has opened a 60-day comment period for stakeholders to offer their opinions on the proposed research guidelines.

It would be great to hear what the initial reactions of entities like VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) are regarding the research guidelines published by the FDA.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Third-Party Presidential Nominees Push for Marijuana Legalization

With everything that’s been going on for the past six months, from a global pandemic that’s crippled the economy to the protests against police brutality raging across the country, it’s easy to forget that the November ballot is fast approaching. The ballot may very well be a turning point for the cannabis industry. For starters, the Democratic Party made it clear that if it clinches Congress and the White House this coming November, it will make decriminalizing marijuana one of its top priorities, despite presumptive Democratic presidential nominee Joe Biden’s views on the matter.

The presidential nominees for both the Libertarian and Green Parties also support broader drug reform, including legalizing marijuana. During an interview with C-SPAN this month, Libertarian pick Jo Jorgensen said that the biggest problem we have right now isn’t drugs but drug prohibition. “Now, do drugs and alcohol cause problems? Of course, they do. However, they’d be much more manageable if it were legal. What’s the difference between me drinking bourbon in my home and somebody else smoking marijuana in their own home? If there is no victim, there is no crime,” she says.

In a statement released on Twitter, she said that the U.S. prison population jumped from 350,000 to 2.3 million in just 30 years due to ‘Draconian sentence lengths, mandatory minimums, and an increase in the number of drug laws which creates more ‘crimes’.” Ending the failed drug war would be a top priority if elected as it has led to the highest incarceration rate in the world. On day 1, I would pardon ALL nonviolent, victimless offenders in federal prison. If there was no victim, there is no crime.”

During a speech delivered remotely for the Green Party National Convention, Green nominee Howie Hawkins said that drug reform could be a tool to combat mass incarceration. “We’ve got to treat drug abuse as a health problem. You should legalize marijuana and decriminalize the hard drugs like Portugal did. Instead of just throwing people in prison and building the biggest prison industrial system in the world, which Joe Biden had a lot to do with as he wrote the legislative architecture for that as chair of the Senate Judiciary Committee, we should be treating drug addiction as a health problem, not a criminal problem.”

“One of the central changes to policing is to end the war on drugs. 20% of incarcerated people in the U.S. are locked up due to a drug offense. We need to legalize marijuana, decriminalize other drugs, and make treatment readily available like Portugal did.”

Industry watchers say cannabis sector players like VIVO Cannabis Inc. (TSXV: VIVO) (OTCQX: VVCIF) may not put a lot of stock in what these other presidential nominees say since they don’t command a huge following among voters, and can hardly sway the direction of drug policy at the federal level.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – You Don’t Need Lots of Capital to Be Big in the Marijuana Industry

For many young entrepreneurs, launching a startup is pretty straightforward. Make a snazzy business plan, secure as much funding as you can from investors and hit the ground running. However, acquiring startup capital is no easy task and if you do, you and your business are often at the mercy of your investors and advisory boards. More often than not, these entrepreneurs find themselves running businesses that while successful and profitable, have strayed far from their original visions.

But who said that’s the only way to go? It’s certainly the quicker way, you’ll have funds to make all the appropriate moves early in your business’ inception, but the more funding your receive, the more control you lose. If you go in without much investor funding, it will definitely take you longer to gain some ground, but it’s the best way to build and run your business according to your vision and goals.

Cannabis is a relatively new industry, with most dominant players being only a few years old. So while there are plenty of investors willing to throw their hats into the cannabis industry, few have the experience and insight to help a cannabis startup navigate the industry. Ultimately, deciding whether or not to seek investor funding is a major decision that will have far reaching consequences for your business. So before you do, consider this:

Are you raising capital just to stay afloat or to expand? Similar to how you shouldn’t take a loan to fund a wedding or an expensive car, money from investors should ideally be used to expand and create more opportunities for earning. If you are using funds from investors to stay afloat, you are opening yourself up to major headaches in the near future. Additionally, you should consider how much control you want over the business.

Once you receive investor funding, the business isn’t solely yours. New ideas and opportunities will have to be discussed and agreed upon by all owners before any action. If you have too many investors, it will lead to conflicts over which creative direction to take, and you may find yourself at the helm of a company you don’t recognize. If you don’t go for investor funding, you will have complete control over the business, allowing you to make creative choices free from investor pressure.

These issues connected the implications of investor funding may not be so new to established companies like VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) and startups would be well advised to learn from those who have been there before them.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) Issues Update on Global Medical Business

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF), a leading provider of premium cannabis products and services and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited (“Canna Farms”), ABcann Medicinals Inc. (“ABcann”) and Harvest Medicine Inc. (“Harvest Medicine”), today provided an update on its global medical business, which operates in Canada, Germany and Australia. “One of our top strategic priorities is to focus on the global medical cannabis market, directly servicing tens of thousands of patients and investing in product development initiatives that prioritize high-quality novel products,” Barry Fishman, CEO of VIVO, stated in the news release.  “We’ve recently made significant progress on a number of key initiatives, which will help solidify our market presence as a company that is committed to delivering solutions for patients and healthcare professionals on an international scale.”

To view the full press release, visit http://cnw.fm/P2ZDz

About VIVO Cannabis(TM)

VIVO Cannabis(TM) is recognized for trusted, premium cannabis products and services. It holds production and sales licenses from Health Canada and operates world-class indoor and seasonal airhouse cultivation facilities with proprietary plant-growing technology in Hope, British Columbia and Napanee, Ontario. VIVO has a collection of premium brands, each targeting different customer segments, including Canna Farms(TM), Beacon Medical(TM), Fireside(TM), Fireside X(TM), Lumina(TM) and Canadian Bud Collection(TM). The Company is expanding its production capabilities and distribution network. Harvest Medicine, VIVO’s patient-centric, scalable network of medical cannabis clinics, has serviced over 100,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia. The Company has a healthy balance sheet and is well-positioned to accelerate its path to profitability. For more information visit www.VIVOCannabis.com.

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://cnw.fm/VIVO

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) Issues Update on Adult-Use Products

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF), a leading provider of premium cannabis products and services and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited, ABcann Medicinals Inc. and Harvest Medicine Inc., today provided an update on its adult-use cannabis products. According to the update, VIVO recently made initial shipments of its Fireside X shatter product to several provincial wholesalers, representing its second significant concentrates product format launch with an expected significant contribution to the Company’s revenue. “I am pleased to announce that our early shatter sales have exceeded our expectations. We have shipped to the Alberta and Ontario markets, as well as to British Columbia where the provincial wholesaler sold its entire inventory within the first week,” NCC President Gary McMullen said in the news release. “Being first-to-market has been a strong focus for us.”

To view the full press release, visit http://cnw.fm/ScCv1

About VIVO Cannabis(TM)

VIVO Cannabis(TM) is recognized for trusted, premium cannabis products and services. It holds production and sales licenses from Health Canada and operates world-class indoor and seasonal airhouse cultivation facilities with proprietary plant-growing technology in Hope, British Columbia and Napanee, Ontario. VIVO has a collection of premium brands, each targeting different customer segments, including Canna Farms(TM), Beacon Medical(TM), Fireside(TM), Fireside X(TM), Lumina(TM) and Canadian Bud Collection(TM). The Company is expanding its production capabilities and distribution network. Harvest Medicine, VIVO’s patient-centric, scalable network of medical cannabis clinics, has serviced over 100,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia. The Company has a healthy balance sheet and is well-positioned to accelerate its path to profitability. For more information visit www.VIVOCannabis.com.

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://cnw.fm/VIVO

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com